Annual Cash & Cash Equivalents
$6.50 M
+$5.15 M+380.73%
August 31, 2024
Summary
- As of February 26, 2025, LEXX annual cash & cash equivalents is $6.50 million, with the most recent change of +$5.15 million (+380.73%) on August 31, 2024.
- During the last 3 years, LEXX annual cash & cash equivalents has fallen by -$4.42 million (-40.47%).
- LEXX annual cash & cash equivalents is now -40.47% below its all-time high of $10.92 million, reached on August 31, 2021.
Performance
LEXX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$8.08 M
+$1.58 M+24.28%
November 30, 2024
Summary
- As of February 26, 2025, LEXX quarterly cash and cash equivalents is $8.08 million, with the most recent change of +$1.58 million (+24.28%) on November 30, 2024.
- Over the past year, LEXX quarterly cash and cash equivalents has stayed the same.
- LEXX quarterly cash and cash equivalents is now -26.01% below its all-time high of $10.92 million, reached on August 31, 2021.
Performance
LEXX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
LEXX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +380.7% | 0.0% |
| 3 y3 years | -40.5% | +78.2% |
| 5 y5 years | +405.8% | +78.2% |
LEXX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.5% | +380.7% | -16.6% | +497.5% |
| 5 y | 5-year | -40.5% | +405.8% | -26.0% | +1437.8% |
| alltime | all time | -40.5% | >+9999.0% | -26.0% | >+9999.0% |
Lexaria Bioscience Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2024 | - | $8.08 M(+24.3%) |
| Aug 2024 | $6.50 M(+380.7%) | $6.50 M(-23.2%) |
| May 2024 | - | $8.46 M(+79.8%) |
| Feb 2024 | - | $4.71 M(+140.8%) |
| Nov 2023 | - | $1.95 M(+44.5%) |
| Aug 2023 | $1.35 M(-76.7%) | $1.35 M(-57.3%) |
| May 2023 | - | $3.16 M(-3.3%) |
| Feb 2023 | - | $3.27 M(-27.8%) |
| Nov 2022 | - | $4.53 M(-22.0%) |
| Aug 2022 | $5.81 M(-46.8%) | $5.81 M(-17.6%) |
| May 2022 | - | $7.05 M(-15.7%) |
| Feb 2022 | - | $8.36 M(-13.7%) |
| Nov 2021 | - | $9.68 M(-11.3%) |
| Aug 2021 | $10.92 M(+743.9%) | $10.92 M(+34.6%) |
| May 2021 | - | $8.11 M(-13.2%) |
| Feb 2021 | - | $9.35 M(+1679.3%) |
| Nov 2020 | - | $525.30 K(-59.4%) |
| Aug 2020 | $1.29 M(+0.7%) | $1.29 M(-36.4%) |
| May 2020 | - | $2.03 M(+174.9%) |
| Feb 2020 | - | $740.00 K(-44.5%) |
| Nov 2019 | - | $1.33 M(+3.8%) |
| Aug 2019 | $1.29 M(-25.6%) | $1.29 M(-35.6%) |
| May 2019 | - | $2.00 M(-35.5%) |
| Feb 2019 | - | $3.09 M(+16.9%) |
| Nov 2018 | - | $2.64 M(+53.1%) |
| Aug 2018 | $1.73 M(-31.8%) | $1.73 M(-16.3%) |
| May 2018 | - | $2.06 M(-11.0%) |
| Feb 2018 | - | $2.32 M(+4.9%) |
| Nov 2017 | - | $2.21 M(-12.8%) |
| Aug 2017 | $2.53 M(+2612.3%) | $2.53 M(-9.2%) |
| May 2017 | - | $2.79 M(+432.7%) |
| Feb 2017 | - | $523.60 K(+321.6%) |
| Nov 2016 | - | $124.20 K(+33.0%) |
| Aug 2016 | $93.40 K(-64.1%) | $93.40 K(+151.8%) |
| May 2016 | - | $37.10 K(-7.7%) |
| Feb 2016 | - | $40.20 K(-52.1%) |
| Nov 2015 | - | $84.00 K(-67.7%) |
| Aug 2015 | $260.10 K | $260.10 K(-68.7%) |
| May 2015 | - | $832.10 K(+5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2015 | - | $792.00 K(+83.7%) |
| Nov 2014 | - | $431.10 K(-25.5%) |
| Aug 2014 | $703.00 K(+973.3%) | - |
| Jul 2014 | - | $578.50 K(-39.2%) |
| Apr 2014 | - | $951.70 K(+3216.0%) |
| Jan 2014 | - | $28.70 K(-56.2%) |
| Oct 2013 | $65.50 K(-63.7%) | $65.50 K(+138.2%) |
| Jul 2013 | - | $27.50 K(-38.2%) |
| Apr 2013 | - | $44.50 K(+14.4%) |
| Jan 2013 | - | $38.90 K(-78.4%) |
| Oct 2012 | $180.50 K(+478.5%) | $180.50 K(+1000.6%) |
| Jul 2012 | - | $16.40 K(-86.4%) |
| Apr 2012 | - | $120.60 K(-14.2%) |
| Jan 2012 | - | $140.50 K(+350.3%) |
| Oct 2011 | $31.20 K(-50.5%) | $31.20 K(-93.7%) |
| Jul 2011 | - | $494.40 K(+289.9%) |
| Apr 2011 | - | $126.80 K(-54.6%) |
| Jan 2011 | - | $279.60 K(+343.8%) |
| Oct 2010 | $63.00 K(-80.9%) | $63.00 K(-85.4%) |
| Jul 2010 | - | $431.40 K(+3.6%) |
| Apr 2010 | - | $416.30 K(-6.6%) |
| Jan 2010 | - | $445.90 K(+35.0%) |
| Oct 2009 | $330.20 K(-50.7%) | $330.20 K(+37.8%) |
| Jul 2009 | - | $239.70 K(+21.1%) |
| Apr 2009 | - | $198.00 K(-45.7%) |
| Jan 2009 | - | $364.80 K(-45.5%) |
| Oct 2008 | $669.60 K(+757.4%) | $669.60 K(+172.6%) |
| Jul 2008 | - | $245.60 K(+391.2%) |
| Apr 2008 | - | $50.00 K(-51.2%) |
| Jan 2008 | - | $102.40 K(+31.1%) |
| Oct 2007 | $78.10 K(-93.9%) | $78.10 K(-91.5%) |
| Jul 2007 | - | $920.10 K(+3072.8%) |
| Apr 2007 | - | $29.00 K(-93.2%) |
| Jan 2007 | - | $426.70 K(-66.8%) |
| Oct 2006 | $1.29 M(+48.8%) | $1.29 M(>+9900.0%) |
| Jul 2006 | - | $6500.00(-94.3%) |
| Apr 2006 | - | $113.90 K(-45.7%) |
| Jan 2006 | - | $209.80 K |
| Oct 2005 | $863.60 K | - |
FAQ
- What is Lexaria Bioscience annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Lexaria Bioscience?
- What is Lexaria Bioscience annual cash & cash equivalents year-on-year change?
- What is Lexaria Bioscience quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly cash and cash equivalents year-on-year change?
What is Lexaria Bioscience annual cash & cash equivalents?
The current annual cash & cash equivalents of LEXX is $6.50 M
What is the all time high annual cash & cash equivalents for Lexaria Bioscience?
Lexaria Bioscience all-time high annual cash & cash equivalents is $10.92 M
What is Lexaria Bioscience annual cash & cash equivalents year-on-year change?
Over the past year, LEXX annual cash & cash equivalents has changed by +$5.15 M (+380.73%)
What is Lexaria Bioscience quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LEXX is $8.08 M
What is the all time high quarterly cash and cash equivalents for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly cash and cash equivalents is $10.92 M
What is Lexaria Bioscience quarterly cash and cash equivalents year-on-year change?
Over the past year, LEXX quarterly cash and cash equivalents has changed by $0.00 (0.00%)